Scientific Advisory Committee Archives

Racehorse doping prevention and identification focus of three research studies: Horsetalk 1/14/19

Press Release: Tackling the use of illicit substances in the horse world has advanced in recent month with three “tactical research” studies by the Racing Medication and Testing Consortium (RMTC). Tactical research studies focus on detecting, identifying and inhibiting the use of illicit substances. The first study to be published, L-and D-threo Ethylphenidate Concentrations, Pharmacokinetics and Pharmacodynamics in

Study Suggests Need For Another Revision To Uniform Drug Guidelines: The Paulick Report 09/14/17

By: Natalie Voss Recommended withdrawal guidelines for detomidine, commercially known as Dormosedan, may face review after a recent study suggested horses could test positive while adhering to the guidelines. The current guideline from the Racing Medication Testing Consortium suggests the threshold for a positive be set at 2ng/ml in urine and 1 ngl/ml in blood,

RCI Board Approves Cobalt Regulations: The Blood-Horse 4/23/15

RMTC By Tom LaMarra The Association of Racing Commissioners International board of directors April 23 approved a testing threshold level and penalties for the mineral cobalt, a naturally occurring substance in racehorses. During a meeting in Tampa, Fla., the RCI Drug Testing Standards and Practices Committee took testimony from the Racing Medication and Testing Consortium

RMTC Board: Stanozolol Threshold Eliminated, Ohio Lab Granted Interim Accreditation…9/20/13

NEWS RELEASE September 20, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD: STANOZOLOL THRESHOLD ELIMINATED, OHIO STATE LAB GRANTED INTERIM ACCREDITATION, UNIFORM NATIONAL MEDICATION RULES, PENALTIES AND LAB REFORMS ENDORSED, OUT OF COMPETITION TESTING COMMITTEE FORMED, WALDROP ELECTED TO SUCCEED LEWIS AS CHAIRMAN The board of directors of the Racing Medication and Testing Consortium

Follow Us

Quick Links

Learn About Our:

Who We Are: